Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging

Pharmaceutical Research

Volumn 25, Issue 3, 2008, Pages 512-520

  Kim, Stephanie H ^a,b   Csaky, Karl G ^c   Wang, Nam Sun ^a   Lutz, Robert J ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

Drug transport barrier; Magnetic resonance imaging; Ocular pharmacokinetics; Subconjunctival injection; Transscleral drug delivery

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM ALBUMIN; GADOLINIUM PENTETATE; GALBUIM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 40549145573     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9408-z     Document Type: Article

References (34)

1. 1. P. A. Gaudio 2004 A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation Ocul. Immunol. Inflamm. 12 169 192 15385194 10.1080/092739490500192 1:CAS:528:DC%2BD2cXhtVenu7%2FJ P. A. Gaudio. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul. Immunol. Inflamm. 12:169–192 (2004).
2. 2. R. J. Morris D. McLeod Z. J. Gregor 1989 Subconjunctival injections of antibiotics are used increasingly at the conclusion of intraocular and extraocular procedures Eye 3 Pt 6 860 861 2630371 R. J. Morris, D. McLeod, and Z. J. Gregor. Subconjunctival injections of antibiotics are used increasingly at the conclusion of intraocular and extraocular procedures. Eye 3 (Pt 6):860–861 (1989).
3. 3. H. J. McCartney I. O. Drysdale A. G. Gornall P. K. Basu 1965 An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into the normal and inflamed rabbit eye Invest. Ophthalmol. 4 297 302 14326615 1:CAS:528:DyaF2MXksVSgtrc%3D H. J. McCartney, I. O. Drysdale, A. G. Gornall, and P. K. Basu. An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into the normal and inflamed rabbit eye. Invest. Ophthalmol. 4:297–302 (1965).
4. 4. O. Weijtens E. J. Feron R. C. Schoemaker A. F. Cohen E. G. Lentjes F. P. Romijn J. C. Meurs van 1999 High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection Am. J. Ophthalmol. 128 192 197 10458175 10.1016/S0002-9394(99)00129-4 1:CAS:528:DyaK1MXlslylsL8%3D O. Weijtens, E. J. Feron, R. C. Schoemaker, A. F. Cohen, E. G. Lentjes, F. P. Romijn, and J. C. van Meurs. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am. J. Ophthalmol. 128:192–197 (1999).
5. 5. M. Barza A. Kane J. L. Baum 1977 Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit Am. J. Ophthalmol. 83 407 413 848547 1:CAS:528:DyaE2sXhs1Gjt7w%3D M. Barza, A. Kane, and J. L. Baum. Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am. J. Ophthalmol. 83:407–413 (1977).
6. 6. A. Tsuji I. Tamai K. Sasaki 1988 Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits Ophthalmic Res. 20 31 43 3380524 1:CAS:528:DyaL1cXhvFymtb8%3D 10.1159/000266253 A. Tsuji, I. Tamai, and K. Sasaki. Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits. Ophthalmic Res. 20:31–43 (1988).
7. 7. T. W. Kim J. D. Lindsey M. Aihara T. L. Anthony R. N. Weinreb 2002 Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice Invest. Ophthalmol. Vis. Sci. 43 1809 1816 12036983 T. W. Kim, J. D. Lindsey, M. Aihara, T. L. Anthony, and R. N. Weinreb. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest. Ophthalmol. Vis. Sci. 43:1809–1816 (2002).
8. 8. P. H. Kalina J. C. Erie L. Rosenbaum 1995 Biochemical quantification of triamcinolone in subconjunctival depots Arch. Ophthalmol. 113 867 869 7605276 1:STN:280:DyaK2MzivFShuw%3D%3D P. H. Kalina, J. C. Erie, and L. Rosenbaum. Biochemical quantification of triamcinolone in subconjunctival depots. Arch. Ophthalmol. 113:867–869 (1995).
9. 9. D. M. Maurice Y. Ota 1978 The kinetics of subconjunctival injections Jpn. J. Ophthalmol. 22 95 100 D. M. Maurice, and Y. Ota. The kinetics of subconjunctival injections. Jpn. J. Ophthalmol. 22:95–100 (1978).
10. 10. S. K. Li S. A. Molokhia E. K. Jeong 2004 Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging Pharm. Res. 21 2175 2184 15648248 10.1007/s11095-004-7669-3 1:CAS:528:DC%2BD2MXjslOqtw%3D%3D S. K. Li, S. A. Molokhia, and E. K. Jeong. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging. Pharm. Res. 21:2175–2184 (2004).
11. 11. B. Reisfeld S. Blackband V. Calhoun S. Grossman S. Eller K. Leong 1993 The use of magnetic resonance imaging to track controlled drug release and transport in the brain Magn. Reson. Imaging 11 247 252 8455434 10.1016/0730-725X(93)90029-D 1:STN:280:DyaK3s3gsVKntg%3D%3D B. Reisfeld, S. Blackband, V. Calhoun, S. Grossman, S. Eller, and K. Leong. The use of magnetic resonance imaging to track controlled drug release and transport in the brain. Magn. Reson. Imaging. 11:247–252 (1993).
12. 12. B. A. Berkowitz Y. Sato C. A. Wilson E. Juan de 1991 Blood–retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection Invest. Ophthalmol. Vis. Sci. 32 2854 2860 1917389 1:STN:280:DyaK38%2FhtVKktA%3D%3D B. A. Berkowitz, Y. Sato, C. A. Wilson, and E. de Juan. Blood–retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection. Invest. Ophthalmol. Vis. Sci. 32:2854–2860 (1991).
13. 13. E. L. Arrindell J. C. Wu M. D. Wolf S. Nanda D. P. Han E. C. Wong G. W. Abrams W. F. Mieler J. S. Hyde 1995 High-resolution magnetic resonance imaging evaluation of blood–retinal barrier integrity following transscleral diode laser treatment Arch. Ophthalmol. 113 96 102 7826300 1:STN:280:DyaK2M7is1yksQ%3D%3D E. L. Arrindell, J. C. Wu, M. D. Wolf, S. Nanda, D. P. Han, E. C. Wong, G. W. Abrams, W. F. Mieler, and J. S. Hyde. High-resolution magnetic resonance imaging evaluation of blood–retinal barrier integrity following transscleral diode laser treatment. Arch. Ophthalmol. 113:96–102 (1995).
14. 14. B. A. Berkowitz R. Roberts H. Luan J. Peysakhov X. Mao K. A. Thomas 2004 Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats Invest. Ophthalmol. Vis. Sci. 45 2391 2398 15223822 10.1167/iovs.03-1381 B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, X. Mao, and K. A. Thomas. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest. Ophthalmol. Vis. Sci. 45:2391–2398 (2004).
15. 15. W. E. Plehwe D. W. McRobbie R. A. Lerski E. M. Kohner 1988 Quantitative magnetic resonance imaging in assessment of the blood–retinal barrier Invest. Ophthalmol. Vis. Sci. 29 663 670 3366561 1:CAS:528:DyaL1cXks12muro%3D W. E. Plehwe, D. W. McRobbie, R. A. Lerski, and E. M. Kohner. Quantitative magnetic resonance imaging in assessment of the blood–retinal barrier. Invest. Ophthalmol. Vis. Sci. 29:663–670 (1988).
16. 16. H. Kim M. R. Robinson M. J. Lizak G. Tansey R. J. Lutz P. Yuan N. S. Wang K. G. Csaky 2004 Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging Invest. Ophthalmol. Vis. Sci. 45 2722 2731 15277497 10.1167/iovs.04-0091 H. Kim, M. R. Robinson, M. J. Lizak, G. Tansey, R. J. Lutz, P. Yuan, N. S. Wang, and K. G. Csaky. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 45:2722–2731 (2004).
17. 17. S. H. Kim C. J. Galban R. J. Lutz R. L. Dedrick K. G. Csaky M. J. Lizak N. S. Wang G. Tansey M. R. Robinson 2007 Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging Invest. Ophthalmol. Vis. Sci. 48 808 814 17251481 10.1167/iovs.06-0670 S. H. Kim, C. J. Galban, R. J. Lutz, R. L. Dedrick, K. G. Csaky, M. J. Lizak, N. S. Wang, G. Tansey, and M. R. Robinson. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 48:808–814 (2007).
18. 18. H. Kim M. J. Lizak G. Tansey K. G. Csaky M. R. Robinson P. Yuan N. S. Wang R. J. Lutz 2005 Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging Ann. Biomed. Eng. 33 150 164 15771269 10.1007/s10439-005-8974-7 H. Kim, M. J. Lizak, G. Tansey, K. G. Csaky, M. R. Robinson, P. Yuan, N. S. Wang, and R. J. Lutz. Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging. Ann. Biomed. Eng. 33:150–164 (2005).
19. 19. M. R. Robinson S. S. Lee H. Kim S. Kim R. J. Lutz C. Galban P. M. Bungay P. Yuan N. S. Wang J. Kim K. G. Csaky 2006 A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide Exp. Eye Res. 82 479 487 16168412 10.1016/j.exer.2005.08.007 1:CAS:528:DC%2BD28Xos1aktw%3D%3D M. R. Robinson, S. S. Lee, H. Kim, S. Kim, R. J. Lutz, C. Galban, P. M. Bungay, P. Yuan, N. S. Wang, J. Kim, and K. G. Csaky. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp. Eye Res. 82:479–487 (2006).
20. 20. A. Supersaxo W. R. Hein H. Steffen 1990 Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration Pharm. Res. 7 167 169 2137911 10.1023/A:1015880819328 1:CAS:528:DyaK3cXhtlOit7o%3D A. Supersaxo, W. R. Hein, and H. Steffen. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm. Res. 7:167–169 (1990).
21. 21. A. C. Amrite U. B. Kompella 2005 Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration J. Pharm. Pharmacol. 57 1555 1563 16354399 10.1211/jpp.57.12.0005 1:CAS:528:DC%2BD28Xit1Knu7s%3D A. C. Amrite, and U. B. Kompella. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J. Pharm. Pharmacol. 57:1555–1563 (2005).
22. 22. D. N. McLennan C. J. H. Porter S. A. Charman 2005 Subcutaneous drug delivery and the role of the lymphatics Drug Discov Today: Technologies 2 89 10.1016/j.ddtec.2005.05.006 1:CAS:528:DC%2BD2MXpvFOmtL8%3D D. N. McLennan, C. J. H. Porter, and S. A. Charman. Subcutaneous drug delivery and the role of the lymphatics. Drug Discovery Today: Technologies. 2:89 (2005).
23. 23. L. D. Samuels 1987 Lymphoscintigraphy Lymphology 20 4 9 3600035 1:STN:280:DyaL2s3ls1ajtQ%3D%3D L. D. Samuels. Lymphoscintigraphy. Lymphology. 20:4–9 (1987).
24. 24. M. K. Nawaz M. M. Hamad H. M. Abdel-Dayem S. Sadek B. G. Eklof 1990 Tc-99m human serum albumin lymphoscintigraphy in lymphedema of the lower extremities Clin. Nucl. Med. 15 794 799 2292150 10.1097/00003072-199011000-00004 1:STN:280:DyaK3M7lt12hsQ%3D%3D M. K. Nawaz, M. M. Hamad, H. M. Abdel-Dayem, S. Sadek, and B. G. Eklof. Tc-99m human serum albumin lymphoscintigraphy in lymphedema of the lower extremities. Clin. Nucl. Med. 15:794–799 (1990).
25. 25. S. J. Pain R. S. Nicholas R. W. Barber J. R. Ballinger A. D. Purushotham P. S. Mortimer A. M. Peters 2002 Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood J. Nucl. Med. 43 318 324 11884490 S. J. Pain, R. S. Nicholas, R. W. Barber, J. R. Ballinger, A. D. Purushotham, P. S. Mortimer, and A. M. Peters. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J. Nucl. Med. 43:318–324 (2002).
26. 26. G. F. Warner E. L. Dobson N. Pace M. E. Johnston C. R. Finney 1953 Studies of human peripheral blood flow; the effect of injection volume on the intramuscular radiosodium clearance rate Circulation 8 732 734 13106895 1:STN:280:DyaG2c%2Fislyitg%3D%3D G. F. Warner, E. L. Dobson, N. Pace, M. E. Johnston, and C. R. Finney. Studies of human peripheral blood flow; the effect of injection volume on the intramuscular radiosodium clearance rate. Circulation. 8:732–734 (1953).
27. 27. R. B. Sund J. Schou 1964 The determination of absorption rates from rat muscles: An experimental approach to kinetic descriptions Acta. Pharm Toxicol. (Copenh) 21 313 325 1:CAS:528:DyaF2MXks1Sguw%3D%3D R. B. Sund, and J. Schou. The determination of absorption rates from rat muscles: An experimental approach to kinetic descriptions. Acta Pharm. Toxicol. (Copenh). 21:313–325 (1964).
28. 28. J. Blaser H. L. Rieder R. Luthy 1991 Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters Antimicrob. Agents Chemother. 35 837 839 1854165 1:CAS:528:DyaK3MXitl2qsL4%3D J. Blaser, H. L. Rieder, and R. Luthy. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob. Agents. Chemother. 35:837–839 (1991).
29. 29. K. Hirano T. Ichihashi H. Yamada 1982 Studies on the absorption of practically water-insoluble drugs following injection V: Subcutaneous absorption in rats from solutions in water immiscible oils J. Pharm. Sci. 71 495 500 7097491 10.1002/jps.2600710505 1:CAS:528:DyaL38Xit1eit7o%3D K. Hirano, T. Ichihashi, and H. Yamada. Studies on the absorption of practically water-insoluble drugs following injection V: Subcutaneous absorption in rats from solutions in water immiscible oils. J. Pharm. Sci. 71:495–500 (1982).
30. 30. A. J. Fischman N. M. Alpert J. W. Babich R. H. Rubin 1997 The role of positron emission tomography in pharmacokinetic analysis Drug. Metab. Rev. 29 923 956 9421680 10.3109/03602539709002238 1:CAS:528:DyaK1cXhtlGkug%3D%3D A. J. Fischman, N. M. Alpert, J. W. Babich, and R. H. Rubin. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab. Rev. 29:923–956 (1997).
31. 31. S. R. Cherry 2001 Fundamentals of positron emission tomography and applications in preclinical drug development J. Clin. Pharmacol. 41 482 491 11361044 10.1177/00912700122010357 1:CAS:528:DC%2BD3MXjvVaksbw%3D S. R. Cherry. Fundamentals of positron emission tomography and applications in preclinical drug development. J. Clin. Pharmacol. 41:482–491 (2001).
32. 32. O. Langer M. Muller 2004 Methods to assess tissue-specific distribution and metabolism of drugs Curr. Drug Metab. 5 463 481 15578942 10.2174/1389200043335379 1:CAS:528:DC%2BD2cXhtVWhurnK O. Langer, and M. Muller. Methods to assess tissue-specific distribution and metabolism of drugs. Curr. Drug Metab. 5:463–481 (2004).
33. 33. R. Hustinx S. L. Eck A. Alavi 1999 Potential applications of PET imaging in developing novel cancer therapies J. Nucl. Med. 40 995 1002 10452317 1:STN:280:DyaK1MznvFertA%3D%3D R. Hustinx, S. L. Eck, and A. Alavi. Potential applications of PET imaging in developing novel cancer therapies. J. Nucl. Med. 40:995–1002 (1999).
34. 34. M. Dolovich R. Labiris 2004 Imaging drug delivery and drug responses in the lung Proc. Am. Thorac. Soc. 1 329 337 16113454 10.1513/pats.200404-030MS 1:CAS:528:DC%2BD28XhsFGjsL0%3D M. Dolovich, and R. Labiris. Imaging drug delivery and drug responses in the lung. Proc. Am. Thorac. Soc. 1:329–337 (2004).